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Abstract
Background: Replication-deficient recombinant adenoviral vectors based on human serotype 35 (Ad35) are
desirable due to the relatively low prevalence of neutralizing antibodies in the human population. The structure of
the viral genome and life cycle of Ad35 differs from the better characterized Ad5 and these differences require
differences in the strategies for the generation of vectors for gene delivery.
Results: Sequences essential for E1 and E4 function were identified and removed and the effects of the deletions
on viral gene transcription were determined. In addition, the non-essential E3 region was deleted from rAd35
vectors and a sequence was found that did not have an effect on viability but reduced viral fitness. The packaging
capacity of rAd35 was dependent on pIX and vectors were generated with stable genome sizes of up to 104% of
the wild type genome size. These data were used to make an E1-, E3-, E4-deleted rAd35 vector. This rAd35 vector
with multiple gene deletions has the advantages of multiple blocks to viral replication (i.e., E1 and E4 deletions)
and a transgene packaging capacity of 7.6 Kb, comparable to rAd5 vectors.
Conclusions: The results reported here allow the generation of larger capacity rAd35 vectors and will guide the
derivation of adenovirus vectors from other serotypes.
Introduction
Recombinant adenovirus (rAd)-based gene transfer vec-
tors are currently under investigation in a variety of
gene therapy and vaccine clinical trials. There are more
than 370 such clinical trials that are ongoing for broad
applications, including infectious diseases and cancer
therapy http://www.wiley.com//legacy/wileychi/genmed/
clinical/. Many of these trials are of recombinant adeno-
virus (rAd) vectors based on the human serotype 5
(Ad5) yet there are advantages to rAd vectors derived
from other serotypes. The human adenoviruses have
previously been shown to have different prevalence in
populations around the world [1]. Exposure of human
populations to adenovirus serotype 35 (Ad35) has been
shown to be relatively rare based on the prevalence of
Ad35 neutralizing antibodies in sera [1-5]. Because neu-
tralizing antibody could interfere with the efficacy of
viral gene transfer vectors, the low seroprevalence of
Ad35 makes it an attractive candidate for derivation of
viral vectors [1,4,6,7].
The Ad35 genome has an overall organization similar
to all adenoviruses [1,6,8], which facilitated the deriva-
tion of E1-deleted rAd35 vectors. However, the reported
Ad35 genome annotations were based on sequence
homology analyses without experimental evidence and
some of the initial rAd35 vectors were found to have
genetic instability due to the inadvertent deletion of the
promoter for the structural protein IX (pIX) [9]. Thus,
homology analysis was limited in predicting functional
regions of the Ad35 genome. To develop a complex
rAd35 vector with up to three large deletions we
attempted to characterize the Ad35 life cycle relevant to
rAd35 viral vector productivity, stability, and capacity
for foreign DNA. Essential sequences were identified in
E1 and E4, the sequences were deleted, and the effects
of the deletions on viral gene transcription were deter-
mined. The non-essential E3 region was also deleted
from rAd35 vectors and a sequence was found that
unexpectedly affected late fiber gene transcription, with
subsequent effects on viral fitness. The packaging
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sids with pIX packaged viral genomes up to 104% of the
wild type genome size, whereas pIX-deficient capsids
had a packaging limit of less than 100% wild type gen-
o m es i z e .T h e s ed a t aw e r eu s e dt om a k ea nE 1 - ,E 3 - ,
E4-deleted rAd35 vector. This rAd35 vector with multi-
ple gene deletions has the advantages over previous
rAd35 vectors of a second block to viral replication (i.e.,
E1 and E4 deletions) and an expanded transgene packa-
ging capacity totaling 7.6 Kb, comparable to rAd5
vectors.
Results
Ad35 capsid components and identification of the early/
late switch
To facilitate the derivation of rAd35 vectors with multi-
ple genome deletions the protein components of wild
type virions were determined. Twelve significant protein
peaks were identified by reverse-phase HPLC (rp-HPLC)
of purified, denatured viral particles (Figure 1A). Efflu-
ent fractions from rp-HPLC were analyzed for protein
molecular weights by SDS-PAGE and mass spectroscopy
(Table 1). The combination of whole protein or tryptic
peptide molecular weight data determined by mass spec-
troscopy was used in conjunction with the apparent
molecular weights by SDS-PAGE to assign identities to
all of the rp-HPLC peaks and many SDS-PAGE bands.
However, the fiber protein (protein IV) was not identi-
fied by rp-HPLC. The identity of protein IV in SDS-
PAGE was determined by comparing two Ad35 viruses
that differed only in the fiber protein. The wild type
Ad35 fiber protein was predicted to have a molecular
weight of 35.4 kDa while the mutant protein (5kIV), in
which the fiber knob was replaced with that from Ad5,
was 33.9 kDa (Figure 1B). Taken together, these data
allowed the assignment of identities for ten proteins in
rp-HPLC chromatograms and for seven proteins in
SDS-PAGE analysis (Table 1 & Figure 1C).
Because adenovirus transcriptional patterns differ dra-
matically before and after viral genome replication [8],
we determined the onset of viral DNA replication by
QPCR. A549 cells were infected with wild type Ad35
and the number of copies of viral DNA determined at
time points from 1 to 48 hours post-infection (hpi). The
amount of viral DNA remained unchanged from 1 to 8
hpi and then increased, demonstrating that the onset of
viral DNA replication was between 8 and 9 hpi
(Figure 2). This information provided the basis to look
at differences in viral gene expression between the early
and late phases of viral infection. Taken together, these
data allowed for subsequent identification of effects of
deletions on both transcription and protein expression
levels.
Characterization of the Ad35 E1B/pIX region
An objective for optimal rAd vector design was to maxi-
mize the space available in the genome for insertion of
transgene expression cassettes. All coordinates of viral
locations are based on the Ad35 Holden sequence (Gen-
Bank accession number AY128640) To design the lar-
gest deletion of the E1 region we determined if E1B and
pIX transcripts were generated from overlapping gen-
ome sequences that would be perturbed by deletion of
E1B. First, DNA sequencing of a l cDNA library from
Ad35-infected cells identified the polyadenylation site
and the junctions for two introns. The cDNA clones
Figure 1 Identification of Ad35 viral particle proteins. (A) Representative reverse-phase HPLC chromatogram of Ad35 capsid proteins with
identities shown. N-term II, C-term II = amino- and carboxy-terminal portions, respectively, of protein II. (B) Ad35 SDS-PAGE protein IV (fiber)
identification. Ad35 viruses with wild type (WT) fiber or a genetically modified fiber protein containing the Ad5 fiber knob (5kIV) with predicted
molecular masses of 35.4 and 33.9 kDa are indicated by an arrow and arrow head, respectively. Proteins were analyzed by SDS-PAGE and
visualized by Deep Purple stain. Molecular weight markers are in the first lane along with their molecular weight in kDa. (C) SDS-PAGE protein
assignments for Ad5 and Ad35 capsid proteins stained by silver. Purified virus was loaded at 2.5 × 10
10 particles per lane. Molecular weight
markers are in the first lane along with their molecular weight in kDa. Ad35 capsid proteins are annotated to the right.
McVey et al. Virology Journal 2010, 7:276
http://www.virologyj.com/content/7/1/276
Page 2 of 15that included E1B and pIX sequences showed polyade-
nylation occurring at the position equivalent to nucleo-
tide 3952. Thus, the Ad35 E1B and pIX transcripts
utilized the polyadenylation hexanucleotide signal at
nucleotides 3925-3930 and 3929-3934 inclusive. The
left-most splice junction identified in the cDNA library
joined base pairs 2180 and 3231, placing it in the open
reading frame previously annotated to encode the E1b
494R protein which is analogous to Ad5 E1B 55k [6]. A
second splice junction joined base pairs 3402 and 3480,
placing it in the intergenic region between E1B and pIX
coding sequences with the 3’ splice junction (bp 3480)
five nucleotides upstream of the pIX initiation codon.
The proximity of the 3’ splice junction implied that the
promoter for pIX was located farther upstream than
would have been predicted by homology to the well-
characterized species C adenoviruses [10].
Based on the exon - intron junctions found by the
cDNA library analysis and the conserved structure of
human adenovirus E1/pIX regions, a set of probes for
detection of RNA transcripts were designed to span the
predicted introns and exons (Figure 3A). Northern blot
analysis of steady-state RNA from wild type Ad35
Table 1 Identification of Ad35 viral particle proteins.
Protein mass spectroscopy molecular weight (MW)
determination*
Whole protein MW comparison Tryptic peptide
Identification
SDS-PAGE molecular weight**
Protein Experimental,
theoretical (Da)
Δ
(ppm)
No. of
peptides
p-value Identification Apparent
mass
II (Hexon) 107119.25, 107251.20 12.3 n.d. N/A Size and abundance 107 kDa
II, n-term.
fragment
n.d. N/A 4 8.50 × 10
-13 Tryptic peptide fingerprint 16 kDa
II, c-term.
fragment
n.d. N/A n.d. N/A Abundance in RP–HPLC 90 kDa
III (Penton
Base)
n.d., 62916.92 N/A 7 6.30 × 10
-6 SDS-PAGE of RP-HPLC fraction 64.9 kDa
IIIa 64000.63, 63942.38 9.1 10 2.10 × 10
-9 SDS-PAGE of RP-HPLC fraction 61 kDa
IV (Fiber) n.d., 35351.52 N/A n.d. N/A Size shift of modified protein 35.3 kDa
V 40033.65, 40099.01 16.3 5 2.10 × 10
-6 Inference from MW 46 kDa
VI 21783.45, 21728.76 25.2 n.d N/A SDS-PAGE of RP-HPLC fraction 28 kDa
VII 18784.53, 18738.47 24.6 3 Manual
analysis
Inference from MW, silver and Deep Purple
staining intensity
23.8 kDa
VIII 12204.10, 12190.81 10.9 5 1.50 × 10
-9 Inference from MW 12 kDa
VIII, c-term 7644.21, 7697.31 69 n.d. N/A N/A N/A
IX 14149.42, 14193.94 31.4 2 Manual
analysis
Inference from MW and IX deficient virus 14.1 kDa
*Determined by analysis of rp-HPLC fractions.
**Determined by analysis of rp-HPLC fractions and whole, denatured viral particles.
ppm: parts per million.
n.d.: not done.
N/A: not applicable.
Figure 2 Viral DNA synthesis. A549 cells were infected with wt
Ad35 at an MOI of 5 focus forming units (FFU) per cell, the viral
genome number at each time point was determined by qPCR with
primers and probe to pIX coding sequences, standardized to total
DNA, and expressed as viral genomes per ng of total DNA. Triplicate
infections were performed for each time point; standard deviation
error bars shown; hpi = hours post infection.
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Page 3 of 15infected cells detected three distinct transcripts, ‘a’, ‘b’,
and ‘c’ (Figure 3B). A separate northern blot analysis
with strand-specific probes demonstrated the three tran-
scripts were generated from the E1/pIX coding strand
(data not shown). The largest transcript, transcript ‘a,’
hybridized to all four probes, consistent with an mRNA
encoding E1B 214R and 494R proteins, homologs for
Ad5 E1B 19K and 55k proteins, respectively (previously
annotated by sequence homology [6]). Transcript ‘b’
hybridized to probes 1, 3, and 4 but not 2, identifying it
as the doubly spliced transcript found by cDNA analysis.
Transcript ‘b’ would be predicted to encode for E1B 19K
homolog and a modified form of 55K with a predicted
molecular weight of 15K, from removal of an intron as
described for Ad5 [11]. The smallest transcript, ‘c,’
hybridized to only probe 4. In addition, nucleotide 3367
was the 5’-most nucleotide identified with the cDNA
library, consistent with the identification of transcript ‘c’
encoding only pIX. None of the transcripts hybridized
to a probe to the second intron (data not shown) sug-
gesting that all three transcripts were spliced in this
intergenic region. Thus, two alternative spliced tran-
scripts of E1B were identified and the pIX transcript
was identified and shown to have a 5’ untranslated
region in E1B, as annotated in Figure 3A.
Recombinant Ad35 vectors with E1 region deletions
and transgene expression cassettes were constructed
(Figure 3C) and analyzed for E1B and pIX transcription.
RNA from cells infected with the rAd35 vectors were
analyzed by northern blot with the pIX gene probe
(probe 4). Transcript ‘c’ was present in cells infected
with two rAd35 vectors with the deletions d6 and d8,
Figure 3 E1B and pIX transcription mapping. (A) Schematic of E1b and pIX sequences, splice junctions shown as ^ with their coordinates
that were identified by cDNA analysis, and probe locations (not to scale). Base pair coordinates of the probes are: 1 = 1641-1903, 2 = 2527-3046,
3 = 3283-3359, 4 = 3511-3853. Solid thick lines depict transcripts a, b and c as determined from cDNA and northern blot analysis (panel B) with
apparent sizes given to the right in nucleotides (nt). The predicted proteins (boxes) are labeled with the name of their Ad5 homologues pIX,
E1b19K, E1b55K [6], and E1b15K [11]. (B) Northern blot analysis of pIX transcripts in cells infected with wild type Ad35. Probes 1, 2, 3, 4 from
panel A; a, b, c, = RNAs corresponding to putative mRNAs. (C) Schematic of Ad35 E1 region deletions with Ad35 coordinates corresponding to
deletion junctions shown above each line. The viral left ITR, E1A TATAA box, and E1A, E1B, and pIX coding sequences are represented. (D) and
(E) Northern blot analysis of transcripts in cells infected with wild type Ad35 (wt) or Ad35 viruses with E1 deletions and hybridized to probe 4.
Location of transcripts a, b and c are indicated to the left of each blot.
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were not detected (Figure 3D). In contrast, none of the
transcripts were detected in cells infected with a rAd35
vector with the d2 E1 deletion (rAd35E1(d2)), even
though the pIX gene was not deleted from the vector
genome (Figure 3E). The RNA found between transcript
‘a’ and ‘b’ with the d2 deletion was not identified but
could be a transcript that originated from the expression
cassette found in the E1 region [12]. Based on the
assignment of transcript ‘c’ as the pIX-encoding tran-
script, it was predicted that the d6 and d8 deleted
rAd35 vectors would express pIX protein but rAd35E1
(d2) would not. Although the pIX gene has been
demonstrated as non-essential, the pIX protein effects
the structure of the virus particle and its absence from
the mature virion can increase the heat lability of the
capsid and reduce the genome packaging limit, thus
rAd35 vectors with the protein would have desired char-
acteristics. The levels of pIX in the viral capsid were
directly quantified by reverse phase HPLC and the level
of pIX in rAd35E1(d2) virions was found to be ~10% of
Ad35 wild type levels (Figure 4A). Because the d2 dele-
tion was the relatively larger deletion size, it would pro-
vide for a larger capacity for foreign DNA. Thus, we
determined whether the loss of pIX expression effected
two functions of the viral capsid: viral particle integrity
and capacity for packaging DNA. To restore pIX levels
in the d2 genetic background, pIX was expressed from a
heterologous promoter in the d2-deleted rAd35. The
AAV P5 promoter was inserted immediately 5’ of
nucleotide 3419 in the d2 deletion backbone yielding
deletion d5; the resultant rAd35 vector was designated
rAd35E1(d5). Viral particle integrity was assessed by
comparing the stability of virions after heat treatment.
Wild type Ad35 and rAd35E1(d5) did not lose infectivity
at 48°C while the infectivity of rAd35E1(d2) was reduced
more than 100-fold in 20 minutes at 48°C (Figure 4B).
These results are consistent with the pIX function of
stabilizing the capsid and with a previous proposal for
pIX in Ad35 [9]. The level of pIX in purified rAd35E1
(d5) capsids was determined to be equivalent to those of
wild type virus by rp-HPLC and SDS-PAGE (data not
s h o w n ) .T h u s ,l o s so ft r a n s c r i p t‘c’ correlated with loss
of pIX incorporation into the virion such that pIX func-
tion was lost.
The packaging capacities of rAd35 vectors with dele-
tions d2, d5, d6, and d8 were determined by assessing
genetic stability. Genome rearrangements were detected
by PCR analysis of the non-essential CMV expression
cassette in the E1 region. Amplification products not
present in the plasmid control reactions indicated rear-
rangements. A subset of amplification products were
sequenced to confirm their E1 region origin and the
nature of the rearrangement (data not shown). Viruses
with the E1(d2) deletion showed E1 region rearrange-
ments with genomes smaller than 100% of the wild type
Figure 4 Determination of pIX function. (A) Relative abundance of pIX in viral particles. Approximately 1 × 10
11 particles of wild type Ad35 or
Ad35 with the E1 deletion d2 were fractioned as in Figure 1A and collected for subsequent mass spectroscopy analysis. The analysis of the
fraction corresponding to the peak denoted ‘IX’ in Figure 1A is shown here with the viral sources (Ad35 wt and rAd35E1(d2) indicated. The peak
at 14.1 kDa/z is the singly charged protein pIX (1+) and the peak at 7 kDa/z is the doubly charged protein pIX (2+). The abundance of pIX was
normalized to hexon abundance because the two proteins co-eluted. Based on intensity the rAd35E1(d2) virus contains ~10% of wild type pIX
Ad35 levels. (B) Effect of pIX on heat stability of Ad35 virions. Virions were heat treated in triplicate at 48 C for the time indicated and activity
determined by an FFU assay.
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stability of viral genomes between 97.2% and 99.3% of
wild type genome sizes (Table 2). This transition was
reproducible with all 6 viruses ranging in size from 99.3
to 100.4% showing genetic instability while the three
viruses 97.2% and smaller were stable. In contrast,
rAd35 vectors with the d5, d6, and d8 deletions, which
express pIX, were genetically stable with genome sizes
larger than the wild type genome size. The upper packa-
ging limit of Ad35 appeared to be between 103.6% and
103.9% of wild type genome size. An Ad35E1(d6) virus
w i t hag e n o m es i z eo f1 0 3 . 6 %w a ss t a b l et h r o u g ha t
least 5 passages, however Ad35(d8) viruses that were
103.9% and 104.1% started to show weak signs of
genetic rearrangement in the sensitive PCR based packa-
ging assay. This packaging limit is in good accord with
the 105% limit that has been previously reported for
Ad35 [13]. Taken together, the heat lability and genetic
stability results directly demonstrate the importance of
pIX protein in establishing the viral packaging capacity
for Ad35.
The relationship of pIX expression to capsid integrity
provided criteria for the selection of an optimal E1
deletion: maximum deletion of E1 sequences and
retention of native control of pIX expression. The E1
(d8) deletion was selected as the base for further
rAd35 vector development. Recombinant Ad35E1(d8)
vectors contained the largest E1 deletion tested that
maintained wild type level of pIX transcription (tran-
script ‘c’). In addition, the yield of rAd35E1(d8) viral
progeny was consistently high, approximately 100,000
particles per cell when propagated on the 293-ORF6
cell line (data not shown).
The Ad35 E4 Open Reading Frame 6 sequence was
necessary and sufficient for E4 complementation
Deletion of the E4 region would increase the space in
the rAd35 vector genome for foreign DNA and provide
a block to replication of the rAd35 genome in trans-
duced cells. To facilitate the derivation of rAd35 vectors
with multiple genome deletions, the sequences necessary
for E4 function were mapped using Ad35 viruses with
intact E1 regions. E1-wild type, E4-deleted rAd35 viruses
(Figure 5A) were assessed for growth on PC3 cells, a
human prostate cancer cell line without known E4-com-
plementing activity. Viruses with E4 deletions of either
ORF1 + ORF2 (dORF1-2) or ORF1 through ORF4
(dORF1-4) generated similar, although approximately 5-
fold lower, viral progeny as wild type Ad35 (Figure 5B).
In contrast, internal E4 region deletions of ORF4
through ORF6 (AN) and ORF3 through ORF6 (dORF3-
6) generated approximately 100-fold less viral progeny, i.
e., 10 to 20 infectious viral progeny produced per cell.
These results indicated that deletion of ORF6 had the
greatest effect on viral replication and ORF3 sequence
was not sufficient for productive viral infection. In a sec-
ond experiment, a virus with only ORF6 deleted showed
an approximately 50-fold drop in viral progeny com-
pared to wild type, and a virus with deletion of all open
reading frames except ORF3 was also deficient in viral
progeny production (Figure 5C). The ORF3 transcript
was detected in cells infected with the ORF3 virus (data
Table 2 Ad35 viral vector packaging capacities
E1 deletion, transgene Other genome modifications pIX expression Genome size (percent of wt) Stability at Passage 3
d2, no transgene None No 94.92 Stable
d2, green fluorescent protein (GFP) None No 96.96 Stable
Δ447 - 3326, GFP None No 97.22 Stable
d2, secretory alkaline phosphatase None No 99.33 Rearrangements
d2, luciferase None No 99.79 Rearrangements
d2, bacterial beta-glucuronidase None No 99.94 Rearrangements
d2, HIV Env gp140ΔCFIΔV1V2 None No 99.95 Rearrangements
d2, HIV Env gp140ΔCFI None No 100.41 Rearrangements
d2, lacZ None No 103.68 Rearrangements
d8, eGFP E3(HE), E4(dORF3-6) Yes 85.60 Stable
d8, eGFP E3(HE), E4(dAN) Yes 87.30 Stable
d5^, HIV Env gp140ΔCFIΔV1V2 None Yes 100.43 Stable
d8, HIV Env gp140ΔCFI None Yes 101.70 Stable
d6, Luciferase None Yes 103.60 Stable**
d8, HIV Env gp140ΔCFI Fiber modified* Yes 103.90 Rearrangements
d8, Luciferase Fiber modified* Yes 104.11 Rearrangements
^d2 with AAV P5 promoter for pIX expression.
*Ad35 fiber shaft and knob replaced with Ad5 fiber shaft and simian Ad25 knob.
**Through greater than 5 passages.
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expression was not attempted. Surprisingly, in contrast
to other human serotypes, Ad35 ORF3 was not suffi-
cient to provide E4 activity as demonstrated with the
AN, dORF6, and ORF3 viruses which retained ORF3
sequence. Taken together, these data demonstrate that
only ORF6 function must be absent for generating a
replication deficiency.
Transcription analysis of the Ad35 E4 region with
deletions
We next determined the transcriptional profile of the
wild type Ad35 E4 region at early and late time points
prior to deleting portions of the E4 transcription unit. A
northern blot using a probe to the entire E4 region (E4
probe; Figure 6A) identified four and five individual tran-
scripts at 8 and 24 hpi, respectively (Figure 6B). Because
the five late transcripts appeared to include the four early
transcripts and late phase RNA was more abundant, late
phase RNA was used for further analysis. Open reading
frame-specific probes identified three of the transcripts
as having unique 5’ open reading frames (Figure 6B). The
ORF1 probe hybridized to only one transcript, implying
that the ORF1 protein would be expressed from that
transcript only. The ORF2 probe hybridized to the same
transcript as the ORF1 probe and a second, smaller tran-
script, thus the ORF1 sequence was likely removed from
the ORF2-encoding transcript. Similarly, the ORF3 probe
hybridized to an even smaller RNA, suggesting that
ORF1 and ORF2 sequences were absent and the ORF3
protein was expressed from this RNA. The ORF4 and
ORF6 probes gave patterns indistinguishable from the
entire E4 probe. The three predicted alternative spliced
transcripts (ORF1, ORF2, and ORF3) could be aligned to
the E4 region (annotated in Figure 6A). To determine
whether the bands on the blots were E4 transcripts, we
conducted northern blot analyses of RNA from cells
infected with the E4-deleted rAd35 viruses dORF3-6 and
AN. The transcripts identified by the probe for the entire
E4 region decreased in size concomitantly with the E4
deletion in the virus (Figure 6C). A single transcript was
detected with the ORF1 probe, two transcripts with the
ORF2 probe and three transcripts with the ORF3 probe,
while the ORF6 probe did not detect any transcripts in
the E4-deleted rAd35 infected cells. These results con-
firmed the identity of the transcripts generated from the
E4-deleted viruses as the ORF1, ORF2, and ORF3 tran-
scripts. Interestingly, transcripts for neither ORF4 nor
ORF6 were revealed in this analysis. It is possible their
abundance was too low for detection by northern blot or
the proteins are translated from one of the identified
transcripts. The identity of the transcript labeled ‘h’
could not be determined (Figure 6B &6C). The ORF6
probe, which was not strand-specific, detected the tran-
script in cells infected with Ad35 with an intact E4 region
but not in cells infected with rAd35 with ORF6 deleted
(dORF3-6 and AN). However, deletion of these same
sequences (dORF3-6 and AN) did not cause any change
in the size of the h transcript when tested with the com-
plete E4 probe. Thus, it was likely that the ‘h’ transcript
was not generated from the Ad35 E4 region despite
hybridizing to a probe of ORF6 sequences.
Figure 5 Effect of E4 deletions on Ad35 growth. (A) Schematic
of Ad35 E4 region and deletions (not to scale). The previously
identified open reading frames 125R, 145R, 117R, 122R and 299R,
are identified by their corresponding Ad5 open reading frame (ORF)
ORF1, ORF2, ORF3, ORF4 and ORF6 respectively [6]. The Ad35 ORF6/
7 has not been previously described and has coordinates 32,978-
32,805 + 32082-31830. The name of the deletion is given to the
right with the solid lines indicating which E4 sequences are
retained. The description of the junctions are as follows: dORF6
32,010-32,877 with the stop codon of ORF4 changed to TAG, AN
32,007-33,083 with sequence CTAGTCTAGACTAG inserted, dORF3-6
32,010-33,604 with ORF2 stop codon changed to TAG, dORF1-2
33,604-34,416, dORF1-4 32,974-34,416, and ORF3 32,007-33,254 with
sequence GCGCGTCGCGA inserted followed by 33,607-34,416. (B
and C) Generation of viral progeny on the PC3 cell line. Presence
(+) or absence (-) of ORF3 and ORF6 coding sequences is noted
below each rAd. Active viral particles were determined at 72 hpi.
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regulation
For vectors derived from other serotypes, deletion of
non-essential E3 sequences provided more space in the
vector genome for foreign DNA and we sought to
extend this strategy to Ad35. Due to the proximity and
transcription orientations of the E3 and L5 regions, the
effect of E3 deletions on fiber protein gene transcription,
the sole product of L5 was determined. Sequence analy-
sis of lambda cDNA library clones with fiber sequences
identified a tripartite leader sequence with three splice
junctions that joined nucleotides 5962 to 6981, 7052 to
9496, and 9582 to 30830. The identity of the leader
sequence had previously been proposed based on bioin-
formatics [4]. The cDNA analysis also provided identifi-
cation of two sites for polyadenylation addition for the
fiber transcripts, corresponding to nucleotides 31,825
(uracil) and 31,831 (cytidine). The sizes of the cDNAs
for fiber were approximately 1.5 kilobases (kb). North-
ern blot analysis with a fiber sequence probe of RNA
from cells infected with wild type Ad35 identified at
least two major transcripts, one at ~4.0 (kb) and one or
more at ~1.5 kb (Figure 7A, lane “wt”). Strand-specific
probes confirmed the transcripts to be encoded by the
fiber sense strand of the viral genome (data not shown).
Based on the sizes of the cDNAs, the 1.5 kb transcript
was identified as encoding the fiber protein.
Once the fiber transcript was identified, the effects of
E3 region deletions on fiber transcription were deter-
mined. A panel of E3 deletions was generated in the E1-
deleted backbone rAd35(d8) (Figure 7B), and fiber tran-
scripts were analyzed in cells infected with the E1- and
Figure 6 E4 transcriptional analysis. (A) E4 genomic and transcription map with probes used in northern blot analysis (not to scale). Genomic
description is as in Figure 5 with the addition of putative splice donor (SD) and splice acceptor (SA) sites. The names of the identified RNAs are
given to the right. ^ = splicing; An = polyadenylation. Base pair coordinates of probes: ORF1 = 34,045-34,412, ORF2 = 33,611-34,015, ORF3 =
33,258-33,611, ORF4 = 32.882-33,214, ORF6 = 32,012-32,887, E4 = 31,855-34,550. (B) Northern blot analysis of RNA from Ad35 wild type-infected
293-ORF6 cells at 8 and 24 hpi. Probes are indicated above each lane and predicted transcripts are labeled on the left of the gel. Numbers on
the right denote migration of RNA size standards. (C) Northern analysis at 24 hpi of RNA from wild type Ad35 with the following E4 regions: 1 =
wt; 2 = AN; 3 = dORF6. Labeled as in panel B. Identity of transcript h was not determined.
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Page 8 of 15E3-deleted rAd35 vectors. The E3(X) deletion appeared
to increase the level of both the 4.0 kb and 1.5 kb fiber
transcripts and a new RNA of approximately 6.0 kb was
detected (Figure 7A). Phosphoimager quantification of
the 1.5 kb and 4.0 kb bands showed a 2-3 fold increase
relative to wild type Ad35 and rAd35(d8) (data not
shown), while the level of the pIX transcript did not
change. In contrast, E3 deletions SB, HB and HE did
not affect the quantity or size of the fiber transcripts
(Figure 7A). Therefore, the sequences between 27,607
and 30,409 were not required for proper fiber transcrip-
tion. However, sequences between 27,240 and 27,608
effected fiber transcription. A polyadenylation signal for
L4 is present in this region [14] and the 6.0 kb tran-
script found with the E3(X) deletion may represent L4
transcript(s) using the fiber polyadenylation signal, even
Figure 7 Effect of E3 deletions on fiber transcription and virus fitness. (A) Northern blot of 24 hpi total RNA from 293-ORF6 cells infected
with wild type Ad35 (wt), E1-deleted rAd35 (d8), or rAd35 d8 constructs with the E3 deletions noted in panel B. The blot was hybridized with a
fiber (top) or pIX probe (bottom); the fiber and pIX transcripts are labeled. Numbers on the right denote migration of RNA size standards
(kilobases). (B) Schematic of the Ad35 E3 region and E3 deletions (not to scale). The coordinates of the nucleotides that form the deletion
junctions are shown above the lines. L4 poly(A), E3 poly(A) = L4 and E3 polyadenylation hexanucleotide signals, respectively. (C) and (D) Viral
vector growth competitions. rAd35 d8 E1-deleted vector was mixed with (C) rAd35 d8, E3(X)-deleted vector or with (D) rAd35 d8, E3(HE)-deleted
vector. Relative change in genome amounts was determined by DNA restriction fragment analysis of the input mixture of viruses and each serial
passage. DNA restriction fragment analysis uniquely identified each virus genome, which is indicated to the left of the gel and their fragment
sizes in bp on the right. I = input mixed viruses used for initial infection; M = mock infected cells; P1 = initial infection; P4 = fourth passage; a, b,
c = replicates. Restriction enzymes EcoRV and BlpI were used in panels C and D respectively.
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(X). The change in relative amount of fiber mRNA
could be reflective of the differential regulation of polya-
denylation signal usage by the late transcription unit.
Despite the altered late gene expression, the rAd35
(d8) vector with the E3(X) deletion was efficiently res-
cued and grew to high titers. However, the productivity
of the rAd35(d8) with the E3(X) deletion was 2- to 3-
fold lower than the E1-deleted rAd35(d8) (data not
shown). The effects of the E3 deletions were further
evaluated. The relative fitness of E1-deleted vectors with
and without E3 deletions was determined in virus com-
petition experiments by co-infecting 293-ORF6 cells
with equal amounts of purified virus particles from two
viruses and serial passaging the resultant cell-virus
lysates three times. The presence of each viral genome
was determined by restriction digest of total DNA har-
vested from each lysate. The E3(X) virus could not be
detected in the lysate from the first infection (Figure
7C), whereas the E3(HE)-deleted vector genome per-
sisted at its relative input level through the rounds of
infections (Figure 7D). Therefore, the E3(X) deletion
conferred a dramatic reduction in fitness relative to E1-
deleted rAd35. In contrast, the double-deletion rAd35
vector E1(d8) with the largest E3 deletion, HE, showed
no reduction in relative fitness and its viral productivity
was comparable to rAd35 with only an E1(d8) deletion,
86,000 and 98,000 pu/cell respectively. Thus, the E3(HE)
deletion maintained proper fiber transcription, viral fit-
ness, and good virus productivity. The E3(HE) deletion
provides 2801 bp of space for foreign DNA.
Generation of triple-deletion rAd35 vectors
Identification of an appropriate E4 deletion for a triple-
deletion rAd35 vector was undertaken. The two
preferential E4 deletions were initially incorporated into
E1-deleted rAd35. Vectors with the combination of the
E1 d8 deletion with the E4(AN) and E4(dORF3-6)
deletions yielded viral progeny on 293-ORF6 cells com-
parable to the E1-deleted vector (Table 3). Thus, multi-
ple-deletion rAd35 vectors were generated with
favorable growth characteristics, deficits in E1 and E4
function, and complete absence of homology between
the virus E4 region and E4Orf6 sequences in the pro-
duction cell line.
To further expand the utility of rAd35 vectors a triple-
deleted vector was designed. The replication-deficient
vector incorporated the deletions that had the least
impact on virus function while maximizing the amount
of space available for heterologous sequences. The com-
bination of E1(d8), E3(HE), and E4(AN) provided these
characteristics. In addition, rAd35 vectors with this
combination of deletions yielded 36,000 pu/cell, which
is comparable to the E1-deleted rAd35 (Table 3). The
vector has the capacity to accommodate 6,347 bps of
heterologous sequence and still remain at only 100% of
wild type genome size. The vector genome was stable;
no rearrangements were detected by the PCR assay in
the E1, E3 and E4 regions after 10 serial passages of
cell-virus lysate. In addition, protein composition of the
capsid was found to be indistinguishable from wild type
Ad35 in SDS-PAGE analysis (data not shown). This ease
of construction, genetic stability, high productivity,
reduced potential to generate a replication competent
adenovirus (RCA) by homologous recombination with
the production cell line, and expanded heterologous
packaging capacity makes the triple-deleted vector con-
figuration particularly suitable for use with large expres-
sion cassettes and commercial manufacturing purposes.
To our knowledge this is the first E1-, E3-, E4-deleted
rAd35 vector produced.
Discussion
A combination of biochemical and biological approaches
was used to derive multiple rAd35 vectors with the best
replication capacity and ability to accept large insertions
of DNA. Analysis of the regions of the genome targeted
for deletion provided information for optimal vector
design for rAd35 vectors with one, two, or three dele-
tions. The construction of rAd35 viruses with E1 and/or
E4 deletions and the analyses of the E1 and E4 regions
were dependent on the 293-ORF6 cell line which pro-
vided E1 and E4 complementing activity. The 293-ORF6
cell line, which expresses Ad5 E1 and Ad5 E4 ORF6
gene products, has been shown to complement replica-
tion-deficient vectors derived from many serotypes
[15-17].
Transcript and cDNA clone analysis provided for the
identification of splice junctions and polyA sites for
E1B, pIX, and fiber transcripts, as well as the major E4
transcripts. Previously, the pIX transcript was identi-
fied to have an intron [9]. Here we identified the splice
junctions and show the intron is common to E1B tran-
scripts. This common intron had not been previously
reported and may be a feature of adenoviruses that do
n o th a v ead i s c r e t ep r o m o t e rf o rp I Xp o s i t i o n e d
between the E1B ORF and the pIX ORF as found in
Ad5 [10]. Transcript analysis of fiber gene expression
revealed that deletion of non-essential E3 region
Table 3 Viral progeny yields of Ad35 vectors on
293-ORF6 cells
rAd35 vector Yield (pu/cell)
Ad35 wt 125,893
Ad35E1(d8) 77,839
Ad35E1(d8)E4(AN) 58,875
Ad35E1(d8)E3(HE)E4(AN 36,000
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Page 10 of 15sequence can effect fiber late gene expression. Deletion
of the L4 polyA signal sequence [14] in the E3 region
created a large new transcript that was generated from
the fiber polyA signal, thus the E3 polyA signal was
skipped, at least during the late phase of infection, and
fiber transcription was increased, relative to wild type
Ad35 levels. This demonstrates that disruption of gene
expression regulation via deletion of non-essential
sequences can result in viable but under-performing
rAd vectors. Previously described E3-deleted Ad35 vec-
tors removed the putative L4 polyA signal, however, no
assessment of viral productivity or stability was pro-
vided [6].
The packaging capacity of adenovirus type 5 has been
reported as 105% of the wild type Ad5 genome size
[13]. The resultant preparations of Ad5 with genomes of
105% were mixed populations of full length and gen-
omes with spontaneous deletions, thus the large genome
could be packaged into the Ad5 virion but there was a
strong selection for shorter genomes. In contrast, the
Ad35 packaging capacity reported here was defined by
maintenance of genetic stability. Recombinant Ad35 vec-
tors with wild type levels of pIX transcription could
accommodate genomes up to 103.6% of wild type gen-
ome size without signs of deletions or other genetic
instability.
A deletion of the E4 region provides advantages for
rAd vectors. Ad35 E4 sequences were essential for repli-
cation and their removal provided a second block to
replication beyond that obtained by deleting E1.
Removal of the E4 region further diminishes the likeli-
hood that the vaccine vector could revert to replication
competency in the human host while simultaneously
avoiding transformation potential [18]. E1- E3-, E4-
deleted rAd5 vectors display marked decreases in
expression of other adenovirus and cellular genes, rela-
tive to first-generation vectors possessing only the E1 or
E1/E3-deletion(s) [19,20]. This property of the vector
results in reduced toxicity to transduced cells both in
vitro and in vivo [21] and may reduce the induction of
adenovirus-specific T cell activation following immuni-
zation [19]. The E1-E3-E4- rAd35 vector would be pre-
dicted to also have similar properties. Lastly, the E4
deletion provides an additional 1075 bp of space in the
vector genome for insertion of foreign DNA. Thus, the
triple-deletion backbone can stably accommodate 7,600
bp of foreign DNA, based on a genome size of 103.6%.
Conclusions
Ad35 was identified as an attractive candidate for gene
transfer vectors because of hematopoietic stem cell
tropism [7] and neutralizing antibodies to Ad35 are
relatively uncommon in human populations. The fre-
quency of individuals with pre-existing immunity to
Ad35 was found to range from <5% in the USA and
Europe to up to 20% in Africa [1,3,4]. Ad35 vectors
have been extensively tested in animal models of vacci-
nation, as well as in ongoing Phase I trials for HIV
(ClinicalTrials.gov: NCT00479999, NCT00472719,
NCT00801697), malaria (ClinicalTrials.gov:
NCT01018459, NCT00371189), and tuberculosis (Clin-
icalTrials.gov: NCT01017536, NCT01198366). How-
ever, results from the preclinical studies of rAd35
vaccine vectors indicated that transgene-specific
immune responses were markedly lower compared to
Ad5 vectors [22-24]. The lower immunogenicity of
rAd35 vectors may have benefits for gene therapy
applications because administration of rAd35 vectors
to the eye gave prolonged transgene expression relative
to Ad5 vectors [17]. In summary, the data reported
here expanded the knowledge of adenovirus 35 and
vector design and will guide the derivation of complex
adenovirus vectors from other serotypes.
Methods
Reverse-phase high-performance liquid chromatography
(rp-HPLC)
Separation of proteins was accomplished on a 2 × 50
mm Jupiter 300Å C4 column (Phenomenex, Torrance,
California, USA) at 0.2 ml per minute, elution by a
gradient from 20 to 90% of acetonitrile in water, and tri-
fluoroacetic acid at 0.1% was included throughout. Ana-
lytical and semi-preparative scale rp-HPLC was
performed with an 1100 series Agilent LC system. Injec-
tion volumes varied between 5 μL with a maximum of
40 μL depending on viral particle concentrations. Ultra-
violet absorbance at 210 nm was collected continuously
throughout the HPLC analysis. The absorbance at 210
nm was normalized to absorbance at 360 nm to elimi-
nate anomalous absorbance due to scatter. The fractions
corresponding to peaks in the UV absorbance traces
were frozen on dry ice for a minimum of a half-hour.
The fractions were then lyophilized in a rotary lyophili-
zer. Using the procedures applied here minor structural
proteins such as IVa2 or protease were either not
observed or identifiable.
Whole protein mass spectroscopy by MALDI-TOF
The residue in the rp-HPLC fraction tubes that
remained after lyophilization was re-suspended in 50%
acetonitrile and 0.1% TFA typically in a volume of less
than 10% of the original collected volume. A small
volume of the sample was mixed with 20 mg/ml sinna-
pinic acid at a 1-to-1 ratio and 2 μL of this mixture was
spotted and dried on a MALDI target plate along with
protein molecular weight standards such as equine myo-
globin and enolase. A dedicated target plate was used
that had been optimized in the mass spectrometer to
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The machine was run in linear mode and delayed
extraction of ca. 50-600 ns and acceleration voltages as
required for maximum signal-to-noise and resolution
was utilized. The fractioned proteins were also analyzed
by SDS-PAGE allowing for co-identification of the indi-
vidual proteins on both SDS-PAGE and HPLC.
Tryptic peptide mass spectroscopy fingerprints by
MALDI-TOF
The dried rp-HPLC fractions were re-suspended in 50
μL of 25 mM ammonium carbonate and incubated with
0.1 μg of TPCK-treated trypsin at 37°C for 2 hours. The
peptide mixture was mixed 1-to-1 with 10 mg/ml of
a-cyano-4-hydroxycinnamic acid in 50% acetonitrile and
0.1% TFA in water, spotted onto a MALDI target plate
with peptide standards (Bradykinin and Angiotensin)
and analyzed for a peptide fingerprint following calibra-
tion. Typically, the machine was run in reflector mode
a n du t i l i z e dad e l a y e de x t r a c t i o no fc a .5 0 - 2 0 0n sa n d
acceleration voltages as required for maximum signal-
to-noise and resolution. Monoisotopic masses from the
M A L D I - T O Fm a c h i n ew e r em a t c h e dt op r o t e i n sb y
Aldente (version 18/10/2004.) Searches were generally
limited to include only those proteins isolated from viral
sources but not to any specific virus family. The SDS-
PAGE, rp-HPLC, and mass spectrophotometry analyses
determined that purified stocks of wild type Ad35 con-
tained intact and fragmented protein II (hexon).
Ad35 virus description
A lysate of Ad35 was obtained from the American Type
Culture Collection (ATCC, catalog # VR-718D) and a
viral genome cloned into a plasmid by homologous
recombination [25]. The wild type virus and recombi-
nant derivatives were generated from the cloned genome
on 293-ORF6 cells when liberated from the plasmid
backbone. Sequencing of the entire viral genome
revealed it to be nearly identical with the published Hol-
den sequence found at GenBank accession number
AY128640. All genome coordinates referenced in this
manuscript are therefore based on the Holden sequence.
Viral genomes were modified by homologous recombi-
nation in bacteria essentially as previously described
[25,26]. The CMV immediate early promoter and SV40
early polyadenylation signal expression cassette in the
E1 region [27] is oriented to direct transcription toward
the left ITR of the virus except for those viruses with
the d2 deletion in which case it is in the opposite direc-
tion. The junctions of the Ad35 deletions are indicated
in the text. The P5 promoter which directs pIX tran-
scription in the Ad35E1(d5) configuration correspond to
AAV bp 143-309 (ATCC accession number AF043303).
The fiber shaft modified virus (Figure 1B) is an E1(d2)
configuration with a bovine growth hormone polyadeny-
lation signal and expressing HIV glycoprotein 140B in
which Ad35 sequences 31,222-31,797 are replaced with
Ad5 sequences 32,239-32,787 (GenBank accession num-
ber M73260.1) was compared to wild type virus.
Viral vector growth competitions
Virus with either E3 wild type (wt) or E3 deletions (X,
HE) were competed pair wise against each other. All of
the viruses contained a GFP expression cassette in the
E1 (d8) deletion and are therefore E1-deleted or E1-,
E3-deleted. Equal number of virus particles (pu) were
mixed and 293-ORF6 cells were infected at 200 pu/cell
total. 72 hours post infection cells were harvested and
freeze thawed 3 times. Subsequently three sequential
infections were carried out using 50 ul of crude lysate to
infect a 60 cm plate of 293-ORF6 cells in a total volume
of 500 ul before an additional 3.5 ml of DMEM with
10% FBS and 10 mM Zn Cl2 was added. The infections
lasted 72 hrs. Relative levels of viral genomes were
determined following the isolation of total DNA from
the mixed input viral particles of a 200 μla l i q u o to f
lysate using the High Pure Nucleic Acid Kit from Roche
Applied Science (catalog # 11858874001). To distinguish
the E3 wild type and E3 deletion X and wild type from
deletion HE, the viral genomes were restricted with
EcoRV and BlpI endonucleases (New England BioLabs),
respectively, before being resolved on a 0.8% agarose gel
using 0.5% TBE buffer.
Virion temperature lability
Wild type Ad35, an rAd35 with the E1 deletion d2 and
GFP expression cassette, or an rAd35 with the E1 dele-
tion d5 and HIV gp140BΔCFIΔV1V2 expression cassette
were diluted in triplicate to 8 × 10
10 particles/ml in 10
mM Tris pH7.5, 150 mM NaCl to a final volume of 800
ul in 1.5 ml microcentrifuge tubes on ice, then shifted
to 48°C in a water bath. A 150 ul aliquot was removed
at each time point, mixed with ice-cold 150 ul of
DMEM + 5% FBS and kept on ice until tested for activ-
ity in the focus forming unit (FFU) assay. The data were
presented as percentage of maximum activity because
the input concentrations of the viruses were standar-
dized to particle units and the three stocks of viruses
had a 50-fold range in pu:FFU ratios.
Lambda cDNA library construction and cDNA sequencing
To construct the cDNA library total RNA was isolated
using the PerfectPure RNA Cultured Cell Kit (catalog #
230240) from 5Prime using the human lung carcinoma
cell line A549 24 hours post infection with Ad35 wild
type at a moi of 5 FFU/cell. A lambda cDNA library was
constructed by Lofstrand Labs Limited (USA) with a
ZAP Express cDNA Synthesis Kit from Stratagene
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were done essentially according to Current Protocols in
Molecular Biology.
The sequence of the pIX and fiber cDNAs were deter-
mined. Phage containing pIX and fiber cDNA sequences
were identified by probing plaque lifts using DNA labeled
with the North2South Biotin Random Prime Labeling kit
(catalog # 17075) from Thermo Scientific. The pIX and
fiber DNA probes were generated by polymerase chain
reaction (PCR) with primer pairs A35s3511
(GGAGTCTTCAGCCCTTATCTGACA) + A35a3853
(CGGCCACCTGCTGAGAAA) and A35s30987 (AACA
ACCACAGGCGGATCTCT) + A35a31619 (CTATCA-
TAACTAGTCATGTAGTAACATATTCCATGAATG-
TAGTTTTC) respectively. The identified plaques were
picked and phage expanded in culture. The phage lysates
were used to prime PCRs whose products were gel puri-
fied and sequenced on an ABI 3100. The entire cloned
cDNA was amplified using T3 (ATTAACCCTCAC-
TAAAGGGA) and T7 (TAATACGACTCACTATAGG)
flanking primers. In addition PCR products for the 5’ and
3’ portions of the cDNAs were also made and sequenced.
The 5’ specific reactions for pIX and fiber used A35a3853
and A35a31619 respectively along with the flanking pri-
mer CCGCGGATCCGCCCAGTACATGACCTTA. Simi-
larly the cDNA 3’ specific reactions used A35s3511 and
A35s30987 in conjunction with the T7 primer for pIX and
fiber, respectively.
Northern blot analysis
To generate viral RNA 293-ORF6 cells were infected at
a moi of 5 FFU/cell when analyzing E1, pIX and fiber
transcripts, and at a moi of 1 FFU/cell when analyzing
E4 transcripts. Total RNA (5 ug) from viral and mock
infected cells was harvested at 24 hours post infection
except where noted in the manuscript, purified with the
Versagene RNA cell Kit (Gentra Systems, catalog #
VGR-0050CD), resolved on a 1 or 1.3% agarose gel con-
taining 5% formaldehyde in 1 × MOPS buffer. The RNA
was transferred to Immobilon-Ny+ (Millipore, catalog #
INYC13750) rinsed sequentially in 6× SSC and water,
air dried before being UV cross linked (UV Stratalinker
2400). The membrane was wetted with 5× SSPE and
then prehybridized (50% Formamide, 2× SSC, 1% SDS,
5× Denhardt’s and 0.5 mg/ml denatured salmon sperm
DNA) at 42°C for 2-3 hours. Hybridization used the
same buffer with 10% dextran sulphate overnight at 42°
C along with the desired probe (see below) except for
the strand specific probes which used the ULTRAhyb
buffer (Ambion, catalog # AM8670). The membrane
was washed sequentially twice briefly with 2× SSC, twice
with 2× SSC, 0.1% SDS for 30 minutes at room tem-
perature and three times with a solution of 0.5% SSC,
1% SDS at 56°C for 30 minutes each. The blot was air
dried before being visualized using a Typhoon 9400
(Amersham Biosiences).
All probes were labeled with Redivue a-32P dCTP
(Amersham, catalog # AA0075) using the Rediprime II
Random Primer kit (Amersham, catalog # RPN1633)
except for the strand specific probes which were DNA
oligos labeled with g-ATP using T4 kinase (New Eng-
land BioLabs, catalog # M0201). The probes were: The
description of the probes is as follows. The E1b and pIX
probes 1-4 (Figure 3) were generated by PCR with pri-
mer pairs AGGAAGACTAGGCAACTGT + AAAG-
TAAGAAAAGCCACAG (probe 1), GGTGGT
AATAGATACTCA + GCGTTGATGGGAAACAA-
TATGCACAGTAGC (probe 2), CAAGCATGC-
CAGGTTCC + TGCGGGCAATAACCAAATGAT
(probe 3), A35s3511 + A35a3853 (probe 4). The probe
for the 2
nd intron was generated from two oligos
AGTATTGGGAAAACTTTGGGGTGGGATTTTCA-
GATGGACAGATTGAGTAAAAATTTGTTTTTTCTG
TCTTG + CAAGACAGAAAAAACAAATTTTTACT-
CAATCTGTCCATCTGAAAATCCCACCCCAAAGT
TTTCCCAATAC. The fiber probe was generated by
PCR with primer pair A35s30987 + A35a31619. The E4
probes generated by PCR used primer pairs ATAG-
TAGCCTGACGAACAGGT + GCTGATGAGGCT
TTGTATGTG (E4 Orf1), GACAAAATATCTTGCTC
CTGT + GCAGACTAATTCAAAACTAAC (E4 Orf2),
ACGTGGTAACTGGGCTCTGGT + TGCTTGAAA
CGCAATCCAGTT (E4 Orf4).
CACCTTCCCATTTGACAGAATA + TTGGGTTTG
GCGGGATT (E4 Orf6). The E4 Orf3 probe is a sub-
cloned DNA fragment comprising Ad35 base pairs
33258 through 33611. The E4Orf6 probes were an NruI
to DraIII DNA restriction fragment corresponding to
Ad35 coordinates 32,008 through 32,883. The strand
specific probes are A35a3853, A35a31619 and
ACAACGTGGTAACTGGGCTCTGGTGTAAGGGT-
GATGTCTGGCGCATGATG for pIX, fiber and E4,
respectively.
Virus growth analysis
To determine the onset of viral replication, A549 cells
were infected with wild type virus with 5 FFU/cell in tri-
plicate using 60 cm plates. At the times indicated cells
were washed 3× in PBS and total DNA isolated using
the DNeasy Blood and Tissue kit from Qiagen (catalog
# 69506). Viral genomes were quantified in a qPCR on
an ABI 7700 using manufacture recommended condi-
tions with primers CCCCGAATGGAAGTGCC and
CGCTCTTTGGCGGCG along with probe
6FAMTGTTGAGTTGGACA-
TACTCGCGTGCCMGBNFQ purchased from Applied
Biosystems. The level of viral genome was normalized to
ng of total DNA used in the reaction. The standard
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deleted Ad35 viral genome.
E4 complementation assays were carried out on PC-3
cells (Human prostate adenocarcinoma) infected with
E1-wild type, E4-deleted viruses with 3 FFU/cell and
harvested 72 hours post infection. Cells were freeze
thawed 3 times and levels of active viral progeny were
quantified by an FFU assay [15].
Generation of viral progeny was determined on 293-
ORF6 cells which were infected with 1 FFU/cell. Cells
were cultured in DMEM + 5%FBS + 100 um ZnCl2 and
harvested 72 hours post infection. To quantify the num-
ber of particles cells were subjected to three freeze-thaw
cycles, clarified through a 0.2 μmf i l t e r ,a n d1 0 0u l
volume was loaded onto a Poros 50D column (2 mm
diameter, 10 cm length) equilibrated in 25 mM Tris pH
7.5. The column was washed with 25 mM Tris pH 7.5,
vector eluted with 250 mM NaCl, 25 mM Tris pH 7.5,
and particles detected by 214 nm absorbance. The num-
ber of viral particles was quantified by generating a stan-
dard curve using purified Ad35 particles standardized to
A260 particle units [15]. All of the viruses tested had
either the GFP or enhanced GFP (eGFP) gene in the E1
expression cassette.
Vector packaging capacity
Limits on packaging capacity were assessed by testing
for genetic rearrangements using a PCR. Viral genomes
were liberated from its plasmid backbone by restriction
digest, treated with a mixture of phenol:chlorophorm:
isoamyl alcohol (24:24;1), ethanol precipitated and dis-
solved in water. A 60 mM plate of 293-ORF6 cells
were transfected with 4 ug of viral genome using Poy-
lyfect (Qiagen catalog # 301105). Five days post trans-
fection cells were harvested, freeze thawed three times
with 50 ul of lysate diluted to 500 ul with DMEM used
to infect 60 cm plate of 293-ORF6 cells, rocked every
15 minutes for an hour before being fed with 4.5 ml
D M E M+5 % F B S+1 0 0u mZ n C l 2 .T h ev i r u sw a sc o n -
tinued to be expanded using the same passaging regi-
men except cells were harvested at 72 hour post
infection. To detect viral re-arrangement genomes
were purified from 200 ul of lysates using the High
Pure Viral Nucleic Acid kit (Roche, catalog # 11 858
8 7 40 0 1 )i n2 0u lo fw h i c h1u lw a su s e di na2 5u l
PCR (94C 1 min, 30 cycles 94C 30 sec. × 55C 30 sec ×
72C 3.5 min, with a final 72°C 10 min extension) with
primers CGTACCGTGTCAAAGTCTTC and
CGAGTTCTCAATGATCGAGA using Taq polymerase
and Expand High Fidelity PCR buffer (Roch Diagnos-
tics, catalog # 1435094 and 11732641001) and 1.7 ul
resolved on an agarose gel.
Genetic stability analysis
293-ORF6 cells were transfected with the rAd35 geno-
mic plasmids, cell - virus lysates were serial passaged 3
times (cytopathic effect appeared in the first passage),
and viral DNA was extracted for a polymerase chain
reaction (PCR) assay [27] using primers
CGTACCGTGTCAAAGTCTTC and CGAGTTCTCA
ATGATCGAGA.
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